<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The incidence of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> has risen significantly over the last decades </plain></SENT>
<SENT sid="1" pm="."><plain>During esophageal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> many molecular alterations occur that disrupt essential cellular processes, directing the cell to a rapidly proliferating, immortal state </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> that is present in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> creates an environment in which such molecular alterations are both induced and tolerated </plain></SENT>
<SENT sid="3" pm="."><plain>Here, the novel insights in the molecular mechanisms that underlie the development of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> are reviewed, focusing on the role of <z:mp ids='MP_0001845'>inflammation</z:mp>, <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, <z:mpath ids='MPATH_3'>apoptosis</z:mpath> inhibition, <z:mp ids='MP_0000340'>loss of cell</z:mp> cycle control, and <z:mp ids='MP_0000340'>loss of cell</z:mp>-cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>These novel developments will open new perspectives for diagnosis, treatment, and prevention of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
</text></document>